Clinical trial
Efficacy of Intrathecal Clonidine Versus Neostigmine as Adjuvants to Bupivacaine on Postoperative Maternal and Fetal Outcomes After Elective Cesarean Section: A Randomized Double Blind Controlled Trial
NCT05943613 is registered in ClinicalTrials.gov with Assiut University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy of Intrathecal Clonidine Versus Neostigmine as Adjuvants to Bupivacaine on Postoperative Maternal and Fetal Outcomes After Elective Cesarean Section: A Randomized Double Blind Controlled Trial
- Lead sponsor
- Assiut University
- Phase
- Phase 1
- Overall status
- Unknown status
- Start date
- December 1, 2023
- Completion date
- November 30, 2025
- Enrollment
- 111 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.